1. Weekly dupilumab resulted in a significantly increased rate of histologic remission as compared to placebo in patients with eosinophilic ...
1. Introduction of a guideline recommending early peanut introduction to all infants was not associated with significant reduction in prevalence ...
1. Prevalence of food allergy at 36 months was greatest in the skin intervention group and lowest in the allergenic ...
1. Compared to placebo, children who received peanut oral immunotherapy experienced significantly greater desensitization and remission. 2. Younger age at ...
1. Halloween and Easter were holidays identified as having elevated risk for unknown nut and peanut triggered anaphylaxis in Canadian ...
1. After 24 weeks of oral immunotherapy treatment, patients with peanut allergy were able to consume significantly more peanut protein ...
1. Use of histamine 2 receptor antagonists (H2RA) or proton pump inhibitors (PPIs) during the first 6 months of life ...
1. 100% of children with low-risk symptoms such as rash and itching were negative for true penicillin allergies after 3-tier ...
1. The self-administered, subcutaneous C1-inhibitor CSL830 demonstrated a dose-dependent high efficacy in the prophylactic treatment of hereditary angioedema (HAE) attacks ...
1. For patients with moderate to severe seasonal allergic rhinitis, 2 years of sublingual grass pollen immunotherapy was not significantly ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.